XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common stock
Treasury stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income/(loss)
Total stockholders' equity
Non-controlling interest
Preferred stock - series A shares
Preferred stock - series A shares
Preferred Stock
Preferred stock - series B shares
Preferred stock - series B shares
Preferred Stock
Beginning balance (in shares) at Dec. 31, 2021                   2,307,400   2,892,600
Beginning balance at Dec. 31, 2021 $ 500,473 $ 233 $ (1,691) $ 316,162 $ 66,427 $ 1,020 $ 497,295 $ 3,178   $ 51,100   $ 64,044
Beginning balance (in shares) at Dec. 31, 2021   23,146,775                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) 5,631       5,535   5,535 96        
Issuance of shares under dividend reinvestment plan (in shares)   9,739                    
Issuance of shares under dividend reinvestment plan 115     115     115          
Distribution to non-controlling interest (819)             (819)        
Stock-based management fee expense (in shares)   39,558                    
Stock-based management fee expense 437 $ 1   436     437          
Stock based compensation expense (in shares)   8,900                    
Stock-based compensation expense 324     324     324          
Dividends declared and distributions (8,056)       (7,966)   (7,966) (90)        
Other comprehensive income (loss) (9,778)         (9,778) (9,778)          
Reclass of conversion premium - convertible notes (711)     (711)     (711)          
Treasury stock (in shares)   (10,406)                    
Treasury stock (117)   (117)       (117)          
Ending balance (in shares) at Mar. 31, 2022                   2,307,400   2,892,600
Ending balance at Mar. 31, 2022 487,499 $ 234 (1,808) 316,326 63,996 (8,758) 485,134 2,365   $ 51,100   $ 64,044
Ending balance (in shares) at Mar. 31, 2022   23,194,566                    
Beginning balance (in shares) at Dec. 31, 2021                   2,307,400   2,892,600
Beginning balance at Dec. 31, 2021 500,473 $ 233 (1,691) 316,162 66,427 1,020 497,295 3,178   $ 51,100   $ 64,044
Beginning balance (in shares) at Dec. 31, 2021   23,146,775                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) 850                      
Issuance of shares under dividend reinvestment plan (in shares)   17,839                    
Ending balance (in shares) at Jun. 30, 2022                   1,538,881   2,661,119
Ending balance at Jun. 30, 2022 435,792 $ 234 (6,577) 316,758 48,800 (18,696) 433,518 2,274   $ 34,080   $ 58,919
Ending balance (in shares) at Jun. 30, 2022   22,726,572                    
Beginning balance (in shares) at Mar. 31, 2022                   2,307,400   2,892,600
Beginning balance at Mar. 31, 2022 487,499 $ 234 (1,808) 316,326 63,996 (8,758) 485,134 2,365   $ 51,100   $ 64,044
Beginning balance (in shares) at Mar. 31, 2022   23,194,566                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) (4,781)       (4,797)   (4,797) 16        
Issuance of shares under dividend reinvestment plan (in shares)   8,100                    
Issuance of shares under dividend reinvestment plan 85     85     85          
Distribution to non-controlling interest (14)             (14)        
Stock based compensation expense (in shares)   11,597                    
Stock-based compensation expense 347     347     347          
Dividends declared and distributions (8,033)       (7,940)   (7,940) (93)        
Other comprehensive income (loss) (9,938)         (9,938) (9,938)          
Repurchase of preferred stock (in shares)                   (768,519)   (231,481)
Repurchase of preferred stock (24,604)       (2,459)   (24,604)     $ (17,020)   $ (5,125)
Treasury stock (in shares)   (487,691)                    
Treasury stock (4,769)   (4,769)       (4,769)          
Ending balance (in shares) at Jun. 30, 2022                   1,538,881   2,661,119
Ending balance at Jun. 30, 2022 435,792 $ 234 (6,577) 316,758 48,800 (18,696) 433,518 2,274   $ 34,080   $ 58,919
Ending balance (in shares) at Jun. 30, 2022   22,726,572                    
Beginning balance (in shares) at Dec. 31, 2022                 424,949 424,949 1,135,590 1,135,590
Beginning balance at Dec. 31, 2022 $ 337,465 $ 241 (9,532) 322,439 13,275 (25,649) 335,328 2,137   $ 9,411   $ 25,143
Beginning balance (in shares) at Dec. 31, 2022 23,130,956 23,130,956                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) $ (7,364)       (7,394)   (7,394) 30        
Sale of shares (in shares)   345,578                    
Sale of shares 2,427 $ 4   2,423     2,427          
Stock based compensation expense (in shares)   32,912                    
Stock-based compensation expense 600     600     600          
Dividends declared and distributions (6,459)       (6,425)   (6,425) (34)        
Amortization of unrealized loss on debt securities available-for-sale transferred to held-to-maturity 2,033         2,033 2,033          
Other comprehensive income (loss) 3,853         3,853 3,853          
Ending balance (in shares) at Mar. 31, 2023                   424,949   1,135,590
Ending balance at Mar. 31, 2023 332,555 $ 245 (9,532) 325,462 (544) (19,763) 330,422 2,133   $ 9,411   $ 25,143
Ending balance (in shares) at Mar. 31, 2023   23,509,446                    
Beginning balance (in shares) at Dec. 31, 2022                 424,949 424,949 1,135,590 1,135,590
Beginning balance at Dec. 31, 2022 $ 337,465 $ 241 (9,532) 322,439 13,275 (25,649) 335,328 2,137   $ 9,411   $ 25,143
Beginning balance (in shares) at Dec. 31, 2022 23,130,956 23,130,956                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) $ (18,826)                      
Issuance of shares under dividend reinvestment plan (in shares)   0                    
Ending balance (in shares) at Jun. 30, 2023                 424,949 424,949 1,135,590 1,135,590
Ending balance at Jun. 30, 2023 $ 316,840 $ 247 (9,557) 326,279 (17,282) (19,530) 314,711 2,129   $ 9,411   $ 25,143
Ending balance (in shares) at Jun. 30, 2023 23,627,677 23,627,677                    
Beginning balance (in shares) at Mar. 31, 2023                   424,949   1,135,590
Beginning balance at Mar. 31, 2023 $ 332,555 $ 245 (9,532) 325,462 (544) (19,763) 330,422 2,133   $ 9,411   $ 25,143
Beginning balance (in shares) at Mar. 31, 2023   23,509,446                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) (11,462)       (11,486)   (11,486) 24        
Issuance of shares under dividend reinvestment plan (in shares)   0                    
Sale of shares (in shares)   94,012                    
Sale of shares 527 $ 1   526     527          
Stock based compensation expense (in shares)   28,395                    
Stock-based compensation expense 292 $ 1   291     292          
Dividends declared and distributions (5,280)       (5,252)   (5,252) (28)        
Amortization of unrealized loss on debt securities available-for-sale transferred to held-to-maturity 1,139         1,139 1,139          
Other comprehensive income (loss) (906)         (906) (906)          
Treasury stock (in shares)   (4,176)                    
Treasury stock (25)   (25)       (25)          
Ending balance (in shares) at Jun. 30, 2023                 424,949 424,949 1,135,590 1,135,590
Ending balance at Jun. 30, 2023 $ 316,840 $ 247 $ (9,557) $ 326,279 $ (17,282) $ (19,530) $ 314,711 $ 2,129   $ 9,411   $ 25,143
Ending balance (in shares) at Jun. 30, 2023 23,627,677 23,627,677